Tradestie Institutional Equity Comparison Engine

INMB vs ATYR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATYR Overall Edge

ATYR Captures Institutional Edge (2โ€“1 Pillars ยท 1โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to aTyr Pharma, Inc. Common Stock (ATYR) driven by superior Momentum & Technical, Options & Structure while INMB counters with relative strength in Growth & Margin. Fundamentally, INMB trades at N/M Forward P/E with 0.0% operating margin (+257.1% YoY revenue) versus ATYR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, INMB sits in BREAKDOWN (45th %ile IV; Dealer Gamma Walls on Pro) against ATYR sits in UNCLASSIFIED (36th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
INMB N/M vs ATYR N/M Fwd P/E
Growth & Margin Winner INMB
Op Margin 0.0% vs 0.0% ยท YoY +257.1% vs +0.0%
Momentum & Technical Winner ATYR
1Y -32.3% vs +541.4% ยท 52W Pos 4% vs 60%
Options & Structure Winner ATYR
BREAKDOWN (45th %ile IV) vs UNCLASSIFIED (36th %ile IV)
INMB NASDAQ
INmune Bio Inc. Common stock
Biological Products, (No Disgnostic Substances)
$0.96
+1.55% 1D
Market Cap $32.5M
1M Return -37.59%
1Y Return -32.32%
Forward P/E N/M
Unified AI Score
41.5 / 100 SELL
Tech 25.0 Fund 50.0 Flow 69.0 Mom 55.0
ATYR NASDAQ
aTyr Pharma, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$4.83
-7.82% 1D
Market Cap $15.6M
1M Return +2713.05%
1Y Return +541.43%
Forward P/E N/M
Unified AI Score
34.3 / 100 SELL
Tech 50.0 Fund 36.0 Flow 69.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: INMB -32.32% ATYR +541.43% Spread: +573.75 pp (ATYR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period INMB Revenue ATYR Revenue INMB Op. Margin ATYR Op. Margin Margin Edge
FY2019 N/A $0M N/A -5445.0% ATYR
FY2020 $0M $10M -111163.6% -152.2% ATYR
FY2021 $0M N/A -16106.6% N/A INMB
FY2022 $0M $10M -6938.8% -446.8% ATYR
FY2023 $0M $0M -19187.7% -15557.8% ATYR
FY2024 $0M $0M -304535.7% -28899.6% ATYR
FY2025 $0M $0M -94766.0% -40856.3% ATYR

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: INMB (5) vs ATYR (1)
Institutional Metric INMB ATYR Criterion Row Winner
Market Capitalization Scale $32.5M $15.6M Larger Scale INMB
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +257.1% +0.0% Higher Growth INMB
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -76.7% -93.7% Higher ROE INMB
52-Week Range Position Momentum 4% ($1โ€“$3) 60% ($0โ€“$8) Stronger Trend ATYR
Beta / 30D Volatility Risk Regime 2.61ฮฒ ยท 74% Vol -9.57ฮฒ ยท 13806% Vol Lower Realized Risk INMB
Unified Institutional Score Composite Signal 41.5 / 100 (SELL) 34.3 / 100 (SELL) Higher Composite INMB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full INMB vs ATYR Buy Guide
INMB BREAKDOWN
50d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 45th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live INMB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ATYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 36th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ATYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither INMB nor ATYR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.